| 臺大學術典藏 |
2021-07-23T05:40:27Z |
Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy
|
KO KUAN-YIN; Wang S.-Y.; Yen R.-F.; Shiau Y.-C.; Hsu J.-C.; Tsai H.-Y.; Lee C.-L.; Chiu K.-M.; Wu Y.-W. |
| 臺大學術典藏 |
2022-04-26T07:24:38Z |
Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy
|
KUAN-YIN KO; Wang S.-Y.; Yen R.-F.; Shiau Y.-C.; Hsu J.-C.; Tsai H.-Y.; Lee C.-L.; Chiu K.-M.; Wu Y.-W. |
| 臺大學術典藏 |
2019-09-16T09:25:31Z |
Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction
|
Tsai, Szu Ying; Wang, Shan Ying; Tsai, Hao Yuan; Chiu, Kuan Ming; Hsu, Jung Cheng; Lin, Heng Hsu; Shiau, Yu Chien; Tu, Chung Ming; Lee, Chien Lin; YEN-WEN WU; Huang, Shan Hui; YEN-WEN WU;Lee, Chien Lin;Tu, Chung Ming;Shiau, Yu Chien;Lin, Heng Hsu;Hsu, Jung Cheng;Chiu, Kuan Ming;Tsai, Hao Yuan;Wang, Shan Ying;Tsai, Szu Ying;Huang, Shan Hui |
| 臺大學術典藏 |
2020-09-30T08:49:17Z |
Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction
|
Tsai S.-Y.; YEN-WEN WU; Wang S.-Y.; Shiau Y.-C.; Chiu K.-M.; Tsai H.-Y.; Lee C.-L.; Hsu J.-C.; Tu C.-M.; Lin H.-H.; Huang S.-H. |
| 臺大學術典藏 |
2021-03-18T08:54:06Z |
Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction
|
Tsai S.-Y.; YEN-WEN WU; Wang S.-Y.; Shiau Y.-C.; Chiu K.-M.; Tsai H.-Y.; Lee C.-L.; Hsu J.-C.; Tu C.-M.; Lin H.-H.; Huang S.-H. |
| 國立臺灣大學 |
2010 |
Clinical Significance of Regulatory T Cells and Cd8+ Effector Populations in Patients with Human Endometrial Carcinoma
|
張文君; 李朝樹; 黃思誠; 張道遠; 周麗雲; 許博欽; CHANG, WEN-CHUN; LI, CHAO-HSU; HUANG, SU-CHENG; CHANG, DAW-YUAN; CHOU, LI-YUN; SHEU, BOR-CHING |
| 臺大學術典藏 |
2018-09-10T08:22:18Z |
Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma
|
Chang, W.-C. and Li, C.-H. and Huang, S.-C. and Chang, D.-Y. and Chou, L.-Y. and Sheu, B.-C.; BOR-CHING SHEU |
| 臺大學術典藏 |
2020-01-21T08:41:38Z |
Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma
|
WEN-CHUN CHANG; Li C.-H.; Huang S.-C.; Chang D.-Y.; Chou L.-Y.; Sheu B.-C. |
| 臺大學術典藏 |
2020-01-22T06:00:17Z |
Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma
|
Chang W.-C.;Li C.-H.;Huang S.-C.;Chang D.-Y.;Chou L.-Y.;Bor-Ching Sheu; Chang W.-C.; Li C.-H.; Huang S.-C.; Chang D.-Y.; Chou L.-Y.; BOR-CHING SHEU |
| 臺大學術典藏 |
2021-02-03T03:28:44Z |
Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma
|
WEN-CHUN CHANG; Li C.-H.; Huang S.-C.; Chang D.-Y.; Chou L.-Y.; Sheu B.-C. |
